Gov. Gavin Newsom, in a press briefing Wednesday, said the patient is age 18 to 49 and had not received a booster shot because they were not six months out from their original vaccination course.
The person has mild symptoms, has not been hospitalized and is improving, Newsom said.
Dr. Mark Ghaly, California’s Health and Human Services secretary, said the fact that the patient is fully vaccinated and is improving underscores the importance of immunization.
Supermx gloves still.selling good prizes last qtr. Otherwise how to.get ASP of US 78 and still.make 639 millions in just one qtr. Supermx nett margin.was still high at 44 % last qtr. Supermx selling with its own.brand directly to final customers still has good ASP lah. -------------------- GlovesOff Typical sore glove losers. I burn for you la what brand of gloves you want since now all so cheap
It does not matter anymore when is the dividend ex. The fact is nobody wants to buy and also push the price up. Those who stuck high above in the past few days have to find their way.
-A+A KUALA LUMPUR (Dec 2): Share prices of rubber glove makers including Top Glove Corp Bhd and Hartalega Holdings Bhd rebounded on bargain hunting on Thursday (Dec 2) after investors took profit in recent days and as they assessed updates on the Omicron variant of Covid-19.
At 10.16am, Top Glove shares were traded 11 sen or 4.01% higher at RM2.85, while Hartalega’s share price had risen seven sen or 1.11% to RM6.36.
Rakuten Trade Sdn Bhd head of equity sales Vincent Lau told The Edge on Thursday: “For the last two days, we have seen investors booked their profits on glove stocks and today (Thursday), they’re coming back with bargain-hunting activities [following] the selling pressure previously.”“I think this rotational play will stay, especially for glove maker stocks, as investors are still assessing the latest developments surrounding the Omicron variant,” Lau said.
Glove makers have been closely watched since the Covid-19 pandemic started in early 2020 due to gloves being crucial personal protective equipment to curb the spread of the outbreak.
Looking back, share prices of glove makers rose substantially during the onset of Covid-19 in anticipation that the companies will register higher earnings from stronger demand for their products.
However, news of global Covid-19 vaccination progress tempered such sentiment on stronger demand for gloves in recent months before the current Omicron variant rekindled investors' enthusiasm for glove manufacturers.
Even the dividend also have not ex yet, but the price shown like it had ex for more than 5cents. The worst of all gloves. Now you see their game, so better beware of the trap.
The main purpose for Virus to keep on mutate is for its own long term surival, to betteer itself adapt to host human body without casuing too severe illness, its ultimate goals.
our country is doomed having rubbish leaders like Shahidan and so many more who makes decisions on their whims and fancies without considering the impact on the economy
Existing COVID-19 vaccines are likely to be less effective against the emerging Omicron variant, Moderna CEO Stéphane Bancel predicted on Tuesday.
"There is no world, I think, where [the effectiveness] is the same level ... we had with [the] Delta [variant]," he told the Financial Times, while noting that that the drugmaker is still testing its vaccine on Omicron.
"I think it's going to be a material drop," Bancel added. "I just don't know how much because we need to wait for the data. But all the scientists I've talked to . . . are like, 'This is not going to be good.'"
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
GlovesOff
2,499 posts
Posted by GlovesOff > 2021-12-02 08:15 | Report Abuse
Typical sore glove losers. I burn for you la what brand of gloves you want since now all so cheap
**********
just crawl out from his burial plot